-
1
-
-
33646492843
-
Pathophysiology and therapy for haemoglobinopathies. Part I: Sickle cell disease
-
Madigan C, Malik P. Pathophysiology and therapy for haemoglobinopathies. Part I: sickle cell disease. Expert Rev Mol Med. 2006;8(9):1-23.
-
(2006)
Expert Rev Mol Med.
, vol.8
, Issue.9
, pp. 1-23
-
-
Madigan, C.1
Malik, P.2
-
2
-
-
33646492843
-
Pathophysiology and therapy for haemoglobinopathies. Part II: Thalassaemias
-
Urbinati F, Madigan C, Malik P. Pathophysiology and therapy for haemoglobinopathies. Part II: thalassaemias. Expert Rev Mol Med. 2006;8(10):1-26.
-
(2006)
Expert Rev Mol Med.
, vol.8
, Issue.10
, pp. 1-26
-
-
Urbinati, F.1
Madigan, C.2
Malik, P.3
-
3
-
-
2942527412
-
Sickle-cell anemia hemoglobin: The molecular biology of the first "molecular disease" - The crucial importance of serendipity
-
Ingram VM. Sickle-cell anemia hemoglobin: the molecular biology of the first "molecular disease" - the crucial importance of serendipity. Genetics. 2004;167(1):1-7.
-
(2004)
Genetics.
, vol.167
, Issue.1
, pp. 1-7
-
-
Ingram, V.M.1
-
4
-
-
0033584774
-
Perspectives: Molecular medicine. "Sickle cell anemia, a molecular disease"
-
Strasser BJ. Perspectives: molecular medicine. "Sickle cell anemia, a molecular disease". Science. 1999;286(5444):1488-1490.
-
(1999)
Science
, vol.286
, Issue.5444
, pp. 1488-1490
-
-
Strasser, B.J.1
-
5
-
-
58449126877
-
Sickle cell anemia, the first molecular disease: Overview of molecular etiology, pathophysiology, and therapeutic approaches
-
Steinberg MH. Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches. ScientificWorldJournal. 2008;8:1295-1324.
-
(2008)
ScientificWorldJournal.
, vol.8
, pp. 1295-1324
-
-
Steinberg, M.H.1
-
6
-
-
68849083050
-
Integrated, nontargeted ultrahigh performance liquid chromatography/ electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems
-
Evans AM, De Haven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009;81(16):6656-6667.
-
(2009)
Anal Chem.
, vol.81
, Issue.16
, pp. 6656-6667
-
-
Evans, A.M.1
De Haven, C.D.2
Barrett, T.3
Mitchell, M.4
Milgram, E.5
-
7
-
-
79952463251
-
Metabolomics: An integral technique in systems biology
-
Weckwerth W. Metabolomics: an integral technique in systems biology. Bioanalysis. 2011;2(4):829-836.
-
(2011)
Bioanalysis.
, vol.2
, Issue.4
, pp. 829-836
-
-
Weckwerth, W.1
-
8
-
-
34147178810
-
Lack of sphingosine 1-phosphatedegrading enzymes in erythrocytes
-
Ito K, et al. Lack of sphingosine 1-phosphatedegrading enzymes in erythrocytes. Biochem Biophys Res Commun. 2007;357(1):212-217.
-
(2007)
Biochem Biophys Res Commun.
, vol.357
, Issue.1
, pp. 212-217
-
-
Ito, K.1
-
9
-
-
33947634013
-
Erythrocytes store and release sphingosine 1-phosphate in blood
-
Hanel P, Andreani P, Graler MH. Erythrocytes store and release sphingosine 1-phosphate in blood. Faseb J. 2007;21(4):1202-1209.
-
(2007)
Faseb J.
, vol.21
, Issue.4
, pp. 1202-1209
-
-
Hanel, P.1
Andreani, P.2
Graler, M.H.3
-
10
-
-
34247379074
-
Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate
-
Pappu R, et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science. 2007;316(5822):295-298.
-
(2007)
Science
, vol.316
, Issue.5822
, pp. 295-298
-
-
Pappu, R.1
-
11
-
-
0033738368
-
Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis
-
English D, et al. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J. 2000;14(14):2255-2265.
-
(2000)
FASEB J.
, vol.14
, Issue.14
, pp. 2255-2265
-
-
English, D.1
-
12
-
-
84863057277
-
Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis
-
Nagahashi M, et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Res. 2012;72(3):726-735.
-
(2012)
Cancer Res.
, vol.72
, Issue.3
, pp. 726-735
-
-
Nagahashi, M.1
-
13
-
-
68849122050
-
Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice
-
Camerer E, et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest. 2009;119(7):1871-1879.
-
(2009)
J Clin Invest.
, vol.119
, Issue.7
, pp. 1871-1879
-
-
Camerer, E.1
-
14
-
-
0037162031
-
Lipid mediators of angiogenesis and the signalling pathways they initiate
-
English D, Brindley DN, Spiegel S, Garcia JG. Lipid mediators of angiogenesis and the signalling pathways they initiate. Biochim Biophys Acta. 2002;1582(1-3):228-239.
-
(2002)
Biochim Biophys Acta.
, vol.1582
, Issue.1-3
, pp. 228-239
-
-
English, D.1
Brindley, D.N.2
Spiegel, S.3
Garcia, J.G.4
-
15
-
-
0035895735
-
Plateletreleased phospholipids link haemostasis and angiogenesis
-
English D, Garcia JG, Brindley DN. Plateletreleased phospholipids link haemostasis and angiogenesis. Cardiovasc Res. 2001;49(3):588-599.
-
(2001)
Cardiovasc Res.
, vol.49
, Issue.3
, pp. 588-599
-
-
English, D.1
Garcia, J.G.2
Brindley, D.N.3
-
16
-
-
0038218405
-
Sphingosine-1-phosphate: An enigmatic signalling lipid
-
Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003;4(5):397-407.
-
(2003)
Nat Rev Mol Cell Biol.
, vol.4
, Issue.5
, pp. 397-407
-
-
Spiegel, S.1
Milstien, S.2
-
17
-
-
35948936347
-
Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin
-
Sankala HM, et al. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. Cancer Res. 2007;67(21):10466-10474.
-
(2007)
Cancer Res.
, vol.67
, Issue.21
, pp. 10466-10474
-
-
Sankala, H.M.1
-
18
-
-
69249090929
-
Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes
-
Kobayashi N, Kobayashi N, Yamaguchi A, Nishi T. Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. J Biol Chem. 2009;284(32):21192-21200.
-
(2009)
J Biol Chem.
, vol.284
, Issue.32
, pp. 21192-21200
-
-
Kobayashi, N.1
Kobayashi, N.2
Yamaguchi, A.3
Nishi, T.4
-
19
-
-
49949109713
-
Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720
-
Kihara A, Igarashi Y. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720. Biochim Biophys Acta. 2008;1781(9):496-502.
-
(2008)
Biochim Biophys Acta.
, vol.1781
, Issue.9
, pp. 496-502
-
-
Kihara, A.1
Igarashi, Y.2
-
20
-
-
0030958397
-
Transgenic and gene knock-out mouse models of sickle cell anemia and the thalassemias
-
Paszty C. Transgenic and gene knock-out mouse models of sickle cell anemia and the thalassemias. Curr Opin Hematol. 1997;4(2):88-93.
-
(1997)
Curr Opin Hematol.
, vol.4
, Issue.2
, pp. 88-93
-
-
Paszty, C.1
-
21
-
-
1842408336
-
Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease
-
Paszty C, et al. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science. 1997;278(5339):876-878.
-
(1997)
Science
, vol.278
, Issue.5339
, pp. 876-878
-
-
Paszty, C.1
-
22
-
-
84855303523
-
Sphingosine-1-phosphate signaling and its role in disease
-
Maceyka M, Harikumar KB, Milstien S, Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012;22(1):50-60.
-
(2012)
Trends Cell Biol.
, vol.22
, Issue.1
, pp. 50-60
-
-
Maceyka, M.1
Harikumar, K.B.2
Milstien, S.3
Spiegel, S.4
-
23
-
-
51649122574
-
A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia
-
Paugh SW, et al. A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia. Blood. 2008;112(4):1382-1391.
-
(2008)
Blood
, vol.112
, Issue.4
, pp. 1382-1391
-
-
Paugh, S.W.1
-
24
-
-
0020049818
-
Effects of inositol hexasulfate on the oxygen affinity of hemoglobin: Verification of the integral function theory of thermodynamic linkage
-
Ackers GK, Benesch RE, Edalji R. Effects of inositol hexasulfate on the oxygen affinity of hemoglobin: verification of the integral function theory of thermodynamic linkage. Biochemistry. 1982;21(5):875-879.
-
(1982)
Biochemistry
, vol.21
, Issue.5
, pp. 875-879
-
-
Ackers, G.K.1
Benesch, R.E.2
Edalji, R.3
-
25
-
-
33846279380
-
Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes
-
Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21(1):37-47.
-
(2007)
Blood Rev.
, vol.21
, Issue.1
, pp. 37-47
-
-
Kato, G.J.1
Gladwin, M.T.2
Steinberg, M.H.3
-
26
-
-
77953255522
-
SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis
-
Puneet P, et al. SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis. Science. 2010;328(5983):1290-1294.
-
(2010)
Science
, vol.328
, Issue.5983
, pp. 1290-1294
-
-
Puneet, P.1
-
27
-
-
34948815697
-
Maternal disturbance in activated sphingolipid metabolism causes pregnancy loss in mice
-
Mizugishi K, et al. Maternal disturbance in activated sphingolipid metabolism causes pregnancy loss in mice. J Clin Invest. 2007;117(10):2993-3006.
-
(2007)
J Clin Invest.
, vol.117
, Issue.10
, pp. 2993-3006
-
-
Mizugishi, K.1
-
28
-
-
84864292058
-
Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro
-
Yao C, et al. Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro. Mol Oncol. 2012;6(4):392-404.
-
(2012)
Mol Oncol.
, vol.6
, Issue.4
, pp. 392-404
-
-
Yao, C.1
-
29
-
-
69949113620
-
Regulation of histone acetylation in the nucleus by sphingosine-1- phosphate
-
Hait NC, et al. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science. 2009;325(5945):1254-1257.
-
(2009)
Science
, vol.325
, Issue.5945
, pp. 1254-1257
-
-
Hait, N.C.1
-
30
-
-
77953923379
-
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
-
Alvarez SE, et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature. 2010;465(7301):1084-1088.
-
(2010)
Nature
, vol.465
, Issue.7301
, pp. 1084-1088
-
-
Alvarez, S.E.1
-
31
-
-
77952422757
-
Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex
-
Ratajczak MZ, et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia. 2011;24(5):976-985.
-
(2011)
Leukemia.
, vol.24
, Issue.5
, pp. 976-985
-
-
Ratajczak, M.Z.1
-
32
-
-
79955596917
-
Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes
-
Awad AS, et al. Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. Kidney Int. 2011;79(10):1090-1098.
-
(2011)
Kidney Int.
, vol.79
, Issue.10
, pp. 1090-1098
-
-
Awad, A.S.1
-
33
-
-
3242683494
-
Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice
-
Webb M, et al. Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice. J Neuroimmunol. 2004;153(1-2):108-121.
-
(2004)
J Neuroimmunol.
, vol.153
, Issue.1-2
, pp. 108-121
-
-
Webb, M.1
-
34
-
-
19444378586
-
Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation
-
Mostoslavsky G, Kotton DN, Fabian AJ, Gray JT, Lee JS, Mulligan RC. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation. Mol Ther. 2005;11(6):932-940.
-
(2005)
Mol Ther.
, vol.11
, Issue.6
, pp. 932-940
-
-
Mostoslavsky, G.1
Kotton, D.N.2
Fabian, A.J.3
Gray, J.T.4
Lee, J.S.5
Mulligan, R.C.6
-
35
-
-
33947605915
-
Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability
-
Hsu LL, et al. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood. 2007;109(7):3088-3098.
-
(2007)
Blood
, vol.109
, Issue.7
, pp. 3088-3098
-
-
Hsu, L.L.1
|